253 related articles for article (PubMed ID: 26700472)
1. Loss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation procedures.
Gounoue-Kamkumo R; Nana-Djeunga HC; Bopda J; Akame J; Tarini A; Kamgno J
BMC Infect Dis; 2015 Dec; 15():579. PubMed ID: 26700472
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Og4C3 antigen ELISA as a tool for detection of bancroftian filariasis under lymphatic filariasis elimination programme.
Wattal S; Dhariwal AC; Ralhan PK; Tripathi VC; Regu K; Kamal S; Lal S
J Commun Dis; 2007 Jun; 39(2):75-84. PubMed ID: 18338684
[TBL] [Abstract][Full Text] [Related]
3. Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
Wanji S; Amvongo-Adjia N; Koudou B; Njouendou AJ; Chounna Ndongmo PW; Kengne-Ouafo JA; Datchoua-Poutcheu FR; Fovennso BA; Tayong DB; Fombad FF; Fischer PU; Enyong PI; Bockarie M
PLoS Negl Trop Dis; 2015 Nov; 9(11):e0004184. PubMed ID: 26544042
[TBL] [Abstract][Full Text] [Related]
4. Using the AD12-ICT rapid-format test to detect Wuchereria bancrofti circulating antigens in comparison to Og4C3-ELISA and nucleopore membrane filtration and microscopy techniques.
El-Moamly AA; El-Sweify MA; Hafez MA
Parasitol Res; 2012 Sep; 111(3):1379-83. PubMed ID: 22392137
[TBL] [Abstract][Full Text] [Related]
5. Mapping lymphatic filariasis in Loa loa endemic health districts naïve for ivermectin mass administration and situated in the forested zone of Cameroon.
Beng AA; Esum ME; Deribe K; Njouendou AJ; Ndongmo PWC; Abong RA; Fru J; Fombad FF; Nchanji GT; Amambo G; Gandjui NTV; Biholong B; Nko'Ayissi G; Mbia P; Akame J; Enyong PI; Reid SD; Tougoue JJ; Zhang Y; Wanji S
BMC Infect Dis; 2020 Apr; 20(1):284. PubMed ID: 32299374
[TBL] [Abstract][Full Text] [Related]
6. Positivity of Antigen Tests Used for Diagnosis of Lymphatic Filariasis in Individuals Without Wuchereria bancrofti Infection But with High Loa loa Microfilaremia.
Pion SD; Montavon C; Chesnais CB; Kamgno J; Wanji S; Klion AD; Nutman TB; Boussinesq M
Am J Trop Med Hyg; 2016 Dec; 95(6):1417-1423. PubMed ID: 27729568
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the Og34C filter paper technique in lymphatic filariasis prevalence studies.
Reeve D; Melrose W
Lymphology; 2014 Jun; 47(2):65-72. PubMed ID: 25282872
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali.
Coulibaly YI; Coulibaly SY; Dolo H; Konate S; Diallo AA; Doumbia SS; Soumaoro L; Coulibaly ME; Dicko I; Sangare MB; Dembele B; Sangare M; Dembele M; Touré YT; Kelly-Hope L; Polman K; Kyelem D; Traore SF; Bockarie M; Klion AD; Nutman TB
Parasit Vectors; 2016 Dec; 9(1):628. PubMed ID: 27912789
[TBL] [Abstract][Full Text] [Related]
9. Comparison of an immunochromatographic card test with night blood smear examination for detection of Wuchereria bancrofti microfilaria carriers.
Pani SP; Hoti SL; Vanamail P; Das LK
Natl Med J India; 2004; 17(6):304-6. PubMed ID: 15736550
[TBL] [Abstract][Full Text] [Related]
10. Comparison of tests for the detection of circulating filarial antigen (Og4C3-ELISA and AD12-ICT) and ultrasound in diagnosis of lymphatic filariasis in individuals with microfilariae.
Rocha A; Braga C; Belém M; Carrera A; Aguiar-Santos A; Oliveira P; Texeira MJ; Furtado A
Mem Inst Oswaldo Cruz; 2009 Jul; 104(4):621-5. PubMed ID: 19722087
[TBL] [Abstract][Full Text] [Related]
11. A multi-center field study of two point-of-care tests for circulating Wuchereria bancrofti antigenemia in Africa.
Chesnais CB; Awaca-Uvon NP; Bolay FK; Boussinesq M; Fischer PU; Gankpala L; Meite A; Missamou F; Pion SD; Weil GJ
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005703. PubMed ID: 28892473
[TBL] [Abstract][Full Text] [Related]
12. Rapid Wuchereria bancrofti-specific antigen Wb123-based IgG4 immunoassays as tools for surveillance following mass drug administration programs on lymphatic filariasis.
Steel C; Golden A; Kubofcik J; LaRue N; de Los Santos T; Domingo GJ; Nutman TB
Clin Vaccine Immunol; 2013 Aug; 20(8):1155-61. PubMed ID: 23740923
[TBL] [Abstract][Full Text] [Related]
13. [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
Dorkenoo AM; Sodahlon YK; Bronzan RN; Yakpa K; Sossou E; Ouro-Medeli A; Teko M; Seim A; Mathieu E
Bull Soc Pathol Exot; 2015 Aug; 108(3):181-7. PubMed ID: 25476256
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa.
de Souza DK; Owusu IO; Otchere J; Adimazoya M; Frempong K; Ahorlu CS; Boakye DA; Wilson MD
Pan Afr Med J; 2017; 27():65. PubMed ID: 28819487
[TBL] [Abstract][Full Text] [Related]
15. First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards elimination.
Nana-Djeunga HC; Tchouakui M; Njitchouang GR; Tchatchueng-Mbougua JB; Nwane P; Domche A; Bopda J; Mbickmen-Tchana S; Akame J; Tarini A; Epée E; Biholong BD; Zhang Y; Tougoue JJ; Kabore A; Njiokou F; Kamgno J
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005633. PubMed ID: 28662054
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana.
Owusu IO; de Souza DK; Anto F; Wilson MD; Boakye DA; Bockarie MJ; Gyapong JO
Trans R Soc Trop Med Hyg; 2015 Oct; 109(10):628-35. PubMed ID: 26385935
[TBL] [Abstract][Full Text] [Related]
17. Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.
Koroma JB; Bangura MM; Hodges MH; Bah MS; Zhang Y; Bockarie MJ
Parasit Vectors; 2012 Jan; 5():10. PubMed ID: 22236419
[TBL] [Abstract][Full Text] [Related]
18. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
19. Enzyme-linked immunosorbent assay for the diagnosis of Wuchereria bancrofti infection using urine samples and its application in Bangladesh.
Samad MS; Itoh M; Moji K; Hossain M; Mondal D; Alam MS; Kimura E
Parasitol Int; 2013 Dec; 62(6):564-7. PubMed ID: 23988626
[TBL] [Abstract][Full Text] [Related]
20. A practical strategy for responding to a case of lymphatic filariasis post-elimination in Pacific Islands.
Harrington H; Asugeni J; Jimuru C; Gwalaa J; Ribeyro E; Bradbury R; Joseph H; Melrose W; MacLaren D; Speare R
Parasit Vectors; 2013 Jul; 6():218. PubMed ID: 23890320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
